Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Montevialeon Nov 02, 2017 4:59pm
92 Views
Post# 26897131

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Here is the Reddit post

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Here is the Reddit postDoobie...  they defintiely have the money to turn the ship around.  I wouldn't be too concerned about what they report in two weeks.  It really doesnt matter except it might provide more insight as to why the deal between CB and CGC was structured they way it was.  Even poor results shouldnt effect share price all that much because they now have a ton of cash to address their growth plans.  So if anything, they bought more time to turn things around.  Q3 and Q4 should give some indication if their plan is gaining traction...  One advantage of brining on CB is they can now go a lot longer without having to show a profit.  

I would still sit down and have a beer with you....

M

doobiebaby wrote: Monte, on this you and I agree.  To date WEED has not shown a really great quarter.  It has been respectable, but not breakaway.  We need to see breakaway in the #s.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities